Recently, Li et al. [79] reported that Chinese propolis (25 to 100 μg/ml)-treated breast cancer cells showed decreased migration and invasion by targeting glycolysis enzymes and proinflammatory cytokines (TNF-α, IL-6, and NLRP3) in breast cancer cells. This evidence concerns the gene NLRP3 and breast carcinoma.